Donate
Believe in a Cure Gala
New Family
Medical News and Alerts

Recall – CVS Magnesium Citrate Saline Laxative

June 24, 2022

TOPIC: CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor by Vi-Jon: Recall – Due to Microbial Contamination

AUDIENCE: Consumer, Health Professional, Pharmacy, Gastroenterology

ISSUE: Vi-Jon is recalling one lot, 0556808, of CVS Magnesium Citrate Saline Laxative Oral Solution Lemon Flavor, 10 FL OZ (296 mL) because testing identified the affected lot of the product to contain the bacteria Gluconacetobacter liquefaciens.

Risk Statement: Immunocompromised patients, who consume this product, may be at increased risk for invasive infections caused by Gluconacetobacter liquefaciens that could lead to serious, life-threatening adverse health consequences.

To date, Vi-Jon has not received any complaints related to this recall.

For more information about this recall, click on the red button “Read Recall” below.

BACKGROUND: The product is used for relief of occasional constipation (irregularity) and generally produces bowel movement in 1/2 to 6 hours.

RECOMMENDATIONS:

  • Consumers that have this recalled product should stop using and return any remaining product to the place of purchase.
  • Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

  • Consumers with questions regarding this recall can contact the company.
Consumers and health professionals are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report online.
  • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.
Read Recall Button

Related Posts

FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

by | Dec 2, 2024

The Dup15q Alliance is aware of the recent release by the FDA regarding Clonazepam Orally Disintegrating Tablets USP by Endo USA due to potential product carton strength mislabeling. Ongoing investigation identified the possibility that the affected clonazepam product...

Recall – Vigabatrin for Oral Solution USP

Recall – Vigabatrin for Oral Solution USP

by | Dec 12, 2023

TOPIC: Vigabatrin for Oral Solution USP, 500 mg by InvaGen Pharmaceuticals: Recall - Due to Leaking Sachets AUDIENCE: Patient, Health Professional, Pharmacy, Pediatric, Neurology ISSUE: InvaGen Pharmaceuticals is recalling one lot, NB301030, of Vigabatrin for Oral...

FDA Warns of Rare but Serious Drug Reaction

FDA Warns of Rare but Serious Drug Reaction

by | Dec 4, 2023

The Dup15q Alliance is aware of the recent release by the FDA regarding Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam) warning about the risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This adverse event is...